ArticleJournal of thoracic disease2026
Chemoimmunotherapy improves surgical resection rate and survival versus chemotherapy in potentially resectable non-small cell lung cancer: a real-world propensity score-matched study.
Wei Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.